Supreme Court Lets Stand Landmark Drug Ruling
By declining the case, the Court has also protected Zoloft, worth billions of dollars in annual sales, from early generic competition by plaintiff Teva Pharmaceuticals USA.
Israel-based Teva sued Pfizer in May 2003 in the U.S. District Court for the District of Massachusetts.
It sought declaratory judgment that its planned generic version...
To view the full article, register now.